75766 Federal Register / Vol. 79, No. 244 / Friday, December 19, 2014 / Proposed Rules 

V. B. CATEGORIES AND REGULATIONS ABOUT WHICH NCUA WILL SEEK COMMENT LATER

Corporate Credit Unions ................. Corporate credit unions ......................................................................... 12 CFR 704. 

Directors, Officers, and Employees Loans and lines of credit to officials ...................................................... 12 CFR 701.21(d). 

Reimbursement, insurance, and indemnification of officials and employees.12 CFR 701.33. 

Retirement benefits for employees ........................................................ 12 CFR 701.19. 

Management officials interlock .............................................................. 12 CFR 711. 

Fidelity bond and insurance coverage .................................................. 12 CFR 713. 

General authorities and duties of federal credit union directors ........... 12 CFR 701.4. 

Golden parachutes and indemnification payments ............................... 12 CFR 750. 

Money Laundering .......................... Report of crimes or suspected crimes .................................................. 12 CFR 748.1. 

Bank Secrecy Act .................................................................................. 12 CFR 748.2. 

Rules of Procedure ......................... Liquidation (involuntary and voluntary) .................................................. 12 CFR 709 and 710. 

Uniform rules of practice and procedure ............................................... 12 CFR 747, subpart A. 

Local rules of practice and procedure ................................................... 12 CFR 747, subparts B–M 

Safety and Soundness .................... Lending .................................................................................................. 12 CFR 701.21. 

Investments ............................................................................................ 12 CFR 703. 

Supervisory committee audit ................................................................. 12 CFR 715. 

Security programs .................................................................................. 12 CFR 748.0. 

Guidelines for safeguarding member information and responding to 

unauthorized access to member information.

12 CFR 748, Appendices A and B. 

Records preservation program and appendices—record retention; 

catastrophic act preparedness.

12 CFR 749. 

Appraisals .............................................................................................. 12 CFR 722. 

Examination ........................................................................................... 12 CFR 741.1. 

Liquidity and contingency funding plans ............................................... 12 CFR 741.12. 

Regulations codified elsewhere in NCUA’s regulations as applying to 

federal credit unions that also apply to federally insured state-chartered credit unions.

12 CFR 741, subpart B. 

By the National Credit Union 

Administration Board on December 11, 2014. 

Gerard Poliquin, 

Secretary of the Board. 

[FR Doc. 2014–29629 Filed 12–18–14; 8:45 am] 

BILLING CODE 7535–01–P 

DEPARTMENT OF ENERGY 

Federal Energy Regulatory 

Commission 

18 CFR Part 284 

[Docket No. RM14–2–000] 

Coordination of the Scheduling 

Processes of Interstate Natural Gas 

Pipelines and Public Utilities 

AGENCY: Federal Energy Regulatory 

Commission, DOE. 

ACTION: Notice of proposed rulemaking; 

data request to Independent System 

Operators (ISOs) and Regional 

Transmission Organizations (RTOs). 

SUMMARY: On December 12, 2014, 

pursuant to authority delegated to the 

Director, Office of Energy Policy and 

Innovation, a data request was issued to 

each ISO and RTO regarding the effect 

on the reliable and efficient operations 

of natural gas-fired generators of the 

current 9 a.m. CCT start to the Gas Day. 

The requests seek data from the ISOs/

RTOs with respect to derates by natural 

gas generators during the morning ramp 

period. 

DATES: Responses to the data request 

must be filed on or before January 12, 

2015 in Docket No. RM14–2–000. 

Comments on the responses to the data 

request must be filed in the same docket 

within 10 days of the data request 

response, on or before January 22, 2015. 

ADDRESSES: Responses and Comments, 

identified by docket number, may be 

filed in the following ways: 

• Electronic Filing through http://

www.ferc.gov. Documents created 

electronically using word processing 

software should be filed in native 

applications or print-to-PDF format and 

not in a scanned format. 

• Mail/Hand Delivery: Those unable 

to file electronically may mail or handdeliver comments to: Federal Energy 

Regulatory Commission, Secretary of the 

Commission, 888 First Street NE., 

Washington, DC 20426. 

Instructions: For detailed instructions 

on submitting responses and comments, 

see the SUPPLEMENTARY INFORMATION

section of this document. 

FOR FURTHER INFORMATION CONTACT: 

Anna Fernandez (Legal Information), 

Federal Energy Regulatory 

Commission, Office of the General 

Counsel, 888 First Street NE., 

Washington, DC 20426, 202–502– 

6682; 

Caroline Daly Wozniak (Technical 

Information), Federal Energy 

Regulatory Commission, Office of 

Energy Policy and Innovation, 888 

First Street NE., Washington, DC 

20426, 202–502–8931. 

SUPPLEMENTARY INFORMATION: The data 

requests can be obtained over the 

Internet from the Commission’s eLibrary 

system (http://www.ferc.gov/docs-filing/ 

elibrary.asp) under Docket No. RM14– 

2–000 or from the Commission’s Public 

Reference Room during normal business 

hours (8:30 a.m. to 5:00 p.m. Eastern 

time) at 888 First Street NE., Room 2A, 

Washington DC 20426. The full text of 

the data requests are available on 

eLibrary in PDF and Microsoft Word 

format. To access these documents in 

eLibrary, type the docket number 

excluding the last three digits of this 

document in the docket number field. 

All responses and comments will be 

placed in the Commission’s public files 

in Docket No. RM14–2–000, and may be 

viewed, printed, or downloaded 

remotely from the eLibrary system or 

obtained from the Commission’s Public 

Reference Room. The data responses 

and comments are not required to be 

served on other commenters or entities. 

User assistance is available for 

eLibrary and the Commission’s Web site 

during normal business hours from the 

Commission’s Online Support at 202– 

502–6652 (toll free at 1–866–208–3676) 

or email at ferconlinesupport@ferc.gov, 

or the Public Reference Room at (202) 

502–8371, TTY (202) 502–8659. Email 

the Public Reference Room at 

public.referenceroom@ferc.gov. 

mstockstill on DSK4VPTVN1PROD with PROPOSALS

Federal Register / Vol. 79, No. 244 / Friday, December 19, 2014 / Proposed Rules 75767 

1Because the Secretary of the HHS has delegated 

to the Assistant Secretary for Health of the HHS the 

authority to make domestic drug scheduling 

recommendations, for purposes of this notice of 

intent, all subsequent references to ‘‘Secretary’’ 

have been replaced with ‘‘Assistant Secretary.’’ As 

set forth in a memorandum of understanding 

entered into by the HHS, the Food and Drug 

Administration (FDA), and the National Institute on 

Drug Abuse (NIDA), the FDA acts as the lead agency 

within the HHS in carrying out the Assistant 

Secretary’s scheduling responsibilities under the 

CSA, with the concurrence of NIDA. 50 FR 9518, 

Mar. 8, 1985. 

Dated: December 12, 2014. 

Nathaniel J. Davis, Sr., 

Deputy Secretary. 

[FR Doc. 2014–29701 Filed 12–18–14; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

21 CFR Part 1308 

[Docket No. DEA–402] 

Schedules of Controlled Substances: 

Temporary Placement of Three 

Synthetic Cannabinoids Into Schedule 

I 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Notice of intent. 

SUMMARY: The Deputy Administrator of 

the Drug Enforcement Administration is 

issuing this notice of intent to 

temporarily schedule three synthetic 

cannabinoids into schedule I pursuant 

to the temporary scheduling provisions 

of the Controlled Substances Act. The 

substances are: N-(1-amino-3-methyl-1- 

oxobutan-2-yl)-1-(cyclohexylmethyl)- 

1H-indazole-3-carboxamide (common 

name: AB-CHMINACA), N-(1-amino-3- 

methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide (common 

name: AB-PINACA) and [1-(5- 

fluoropentyl)-1H-indazol-3- 

yl](naphthalen-1-yl)methanone 

(common name: THJ-2201). This action 

is based on a finding by the Deputy 

Administrator that the placement of 

these synthetic cannabinoids into 

schedule I of the CSA is necessary to 

avoid an imminent hazard to the public 

safety. Any final order will impose the 

administrative, civil, and criminal 

sanctions and regulatory controls 

applicable to schedule I substances 

under the CSA on the manufacture, 

distribution, possession, importation, 

exportation, research, and conduct of 

instructional activities of these synthetic 

cannabinoids. 

DATES: December 19, 2014. 

FOR FURTHER INFORMATION CONTACT: 

Imelda L. Paredes, Office of Diversion 

Control, Drug Enforcement 

Administration; Mailing Address: 8701 

Morrissette Drive, Springfield, Virginia 

22152; Telephone: (202) 598–6812. 

SUPPLEMENTARY INFORMATION: Any final 

order will be published in the Federal 

Register and may not be effective prior 

to January 20, 2015. 

Legal Authority 

The Drug Enforcement 

Administration (DEA) implements and 

enforces titles II and III of the 

Comprehensive Drug Abuse Prevention 

and Control Act of 1970, as amended. 21 

U.S.C. 801–971. Titles II and III are 

referred to as the ‘‘Controlled 

Substances Act’’ and the ‘‘Controlled 

Substances Import and Export Act,’’ 

respectively, and are collectively 

referred to as the ‘‘Controlled 

Substances Act’’ or the ‘‘CSA’’ for the 

purpose of this action. The DEA 

publishes the implementing regulations 

for these statutes in title 21 of the Code 

of Federal Regulations (CFR), parts 1300 

to 1321. The CSA and its implementing 

regulations are designed to prevent, 

detect, and eliminate the diversion of 

controlled substances and listed 

chemicals into the illicit market while 

providing for the legitimate medical, 

scientific, research, and industrial needs 

of the United States. Controlled 

substances have the potential for abuse 

and dependence and are controlled to 

protect the public health and safety. 

Under the CSA, every controlled 

substance is classified into one of five 

schedules based upon its potential for 

abuse, its currently accepted medical 

use in treatment in the United States, 

and the degree of dependence the drug 

or other substance may cause. 21 U.S.C. 

812. The initial schedules of controlled 

substances established by Congress are 

found at 21 U.S.C. 812(c), and the 

current list of all scheduled substances 

is published at 21 CFR part 1308. 21 

U.S.C. 812(a). 

Section 201 of the CSA, 21 U.S.C. 811, 

provides the Attorney General with the 

authority to temporarily place a 

substance into schedule I of the CSA for 

two years without regard to the 

requirements of 21 U.S.C. 811(b) if he 

finds that such action is necessary to 

avoid imminent hazard to the public 

safety. 21 U.S.C. 811(h). In addition, if 

proceedings to control a substance are 

initiated under 21 U.S.C. 811(a)(1), the 

Attorney General may extend the 

temporary scheduling for up to one 

year. 21 U.S.C. 811(h)(2). 

Where the necessary findings are 

made, a substance may be temporarily 

scheduled if it is not listed in any other 

schedule under section 202 of the CSA, 

21 U.S.C. 812, or if there is no 

exemption or approval in effect for the 

substance under section 505 of the 

Federal Food, Drug, and Cosmetic Act 

(FDCA), 21 U.S.C. 355. 21 U.S.C. 

811(h)(1); 21 CFR part 1308. The 

Attorney General has delegated 

scheduling authority under 21 U.S.C. 

811 to the Administrator of the DEA, 28 

CFR 0.100, who in turn has redelegated 

that authority to the Deputy 

Administrator of the DEA, 28 CFR part 

0, appendix to subpart R. 

Background 

Section 201(h)(4) of the CSA (21 

U.S.C. 811(h)(4)) requires the Deputy 

Administrator to notify the Secretary of 

the Department of Health and Human 

Services (HHS) of his intention to 

temporarily place a substance into 

schedule I of the CSA.1 The Deputy 

Administrator transmitted notice of his 

intent to place AB–CHMINACA, AB– 

PINACA, and THJ–2201 in schedule I 

on a temporary basis to the Assistant 

Secretary by letter dated September 17, 

2014. The Assistant Secretary 

responded to this notice by letter dated 

September 30, 2014, and advised that 

based on a review by the Food and Drug 

Administration (FDA), there are 

currently no investigational new drug 

applications or approved new drug 

applications for AB–CHMINACA, AB– 

PINACA, or THJ–2201. The Assistant 

Secretary also stated that HHS has no 

objection to the temporary placement of 

AB–CHMINACA, AB–PINACA, and 

THJ–2201 into schedule I of the CSA. 

AB–CHMINACA, AB–PINACA, and 

THJ–2201 are not currently listed in any 

schedule under the CSA, a condition of 

21 U.S.C. 811(h)(1). 

To find that placing a substance 

temporarily into schedule I of the CSA 

is necessary to avoid an imminent 

hazard to the public safety, the Deputy 

Administrator is required to consider 

three of the eight factors set forth in 21 

U.S.C. 811(c): The substance’s history 

and current pattern of abuse; the scope, 

duration and significance of abuse; and 

what, if any, risk there is to the public 

health. 21 U.S.C. 811(h)(3). 

Consideration of these factors includes 

actual abuse, diversion from legitimate 

channels, and clandestine importation, 

manufacture, or distribution. 21 U.S.C. 

811(h)(3). 

A substance meeting the statutory 

requirements for temporary scheduling 

may only be placed in schedule I. 21 

U.S.C. 811(h)(1). Substances in schedule 

I are those that have a high potential for 

mstockstill on DSK4VPTVN1PROD with PROPOSALS